Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice

Reproductive Biology

Volumn 14, Issue 1, 2014, Pages 3-8

  Hamilton, Katherine J ^a   Arao, Yukitomo ^a   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Estrogen receptor; Fertility; Genetically modified mouse; Ovary; Transactivation function; Uterus

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ANIMAL; FEMALE; FERTILITY; GENETICALLY ENGINEERED MOUSE STRAIN; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OVARY; PHYSIOLOGY; REVIEW; TRANSACTIVATION FUNCTION; UTERUS;

ESTROGEN RECEPTOR; FERTILITY; GENETICALLY MODIFIED MOUSE; OVARY; TRANSACTIVATION FUNCTION; UTERUS;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FERTILITY; MALE; MICE; MICE, KNOCKOUT; OVARY;

EID: 84897589575     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2013.12.002     Document Type: Review

References (48)

1. Burns K.A., Korach K.S. Estrogen receptors and human disease: an update. Arch Toxicol 2012, 86(10):1491-1504. [epub 01.06.12].
2. Deroo B.J., Korach K.S. Estrogen receptors and human disease. J Clin Invest 2006, 116(3):561-570. [epub 03.03.06].
3. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839. [epub 15.12.95].
4. Couse J.F., Lindzey J., Grandien K., Gustafsson J.A., Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997, 138(11):4613-4621.
5. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
6. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol Rev 2006, 58(4):685-704. [epub 30.11.06].
7. Bourguet W., Germain P., Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 2000, 21(10):381-388. [epub 26.10.06].
8. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 2000, 65(5):227-251. [epub 07.04.00].
9. Green K.A., Carroll J.S. Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Can 2007, 7(9):713-722. [epub 28.08.07].
10. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G., et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000, 55:163-193. discussion 94-5.
11. Jakacka M., Ito M., Weiss J., Chien P.Y., Gehm B.D., Jameson J.L. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 2001, 276(17):13615-13621. [epub 30.03.01].
12. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., et al. Estrogen receptor pathways to AP-1. J. Steroid Biochem Mol Biol 2000, 74(5):311-317.
13. Smith C.L. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 1998, 58(3):627-632. [epub 25.03.98].
14. Madak-Erdogan Z., Kieser K.J., Kim S.H., Komm B., Katzenellenbogen J.A., Katzenellenbogen B.S. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 2008, 22(9):2116-2127. [epub 12.07.08].
15. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr Rev 2007, 28(7):726-741. [epub 06.10.07].
16. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993, 90(23):11162-11166.
17. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995, 9:1441-1454.
18. Hewitt S.C., Kissling G.E., Fieselman K.E., Jayes F.L., Gerrish K.E., Korach K.S. Biological biochemical consequences of global deletion of exon 3 from the E.R. alpha gene. FASEB J 2010, 24(12):4660-4667. [epub 30.07.10].
19. Goulding E.H., Hewitt S.C., Nakamura N., Hamilton K., Korach K.S., Eddy E.M. Ex3alphaERKO male infertility phenotype recapitulates the alphaERKO male phenotype. J Endocrinol 2010, 207(3):281-288. [epub 14.09.10].
20. Curtis S.W., Clark J., Myers P., Korach K.S. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor or knockout mouse uterus. Proc Natl Acad Sci USA 1999, 96(7):3646-3651.
21. Couse J.F., Yates M.M., Walker V.R., Korach K.S. Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta. Mol Endocrinol 2003, 17(6):1039-1053.
22. Zhou Q., Clarke L., Nie R., Carnes K., Lai L.W., Lien Y.H., et al. Estrogen action and male fertility: roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function. Proc Natl Acad Sci USA 2001, 98(24):14132-14137. [epub 08.11.01].
23. Lee K.H., Finnigan-Bunick C., Bahr J., Bunick D. Estrogen regulation of ion transporter messenger RNA levels in mouse efferent ductules are mediated differentially through estrogen receptor (ER) alpha and ER beta. Biol Reprod 2001, 65(5):1534-1541. [epub 24.10.01].
24. Mahato D., Goulding E.H., Korach K.S., Eddy E.M. Spermatogenic cells do not require estrogen receptor-alpha for development or function. Endocrinology 2000, 141(3):1273-1276. [epub 04.03.00].
25. Mahato D., Goulding E.H., Korach K.S., Eddy E.M. Estrogen receptor-alpha is required by the supporting somatic cells for spermatogenesis. Mol Cell Endocrinol 2001, 178(1/2):57-63. [epub 19.06.01].
26. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998, 95(26):15677-15682.
27. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999, 20(3):358-417.
28. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000, 127(19):4277-4291.
29. Couse J.F., Yates M.M., Deroo B.J., Korach K.S. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology 2005, 146(8):3247-3262.
30. Couse J.F., Hewitt S.C., Bunch D.O., Sar M., Walker V.R., Davis B.J., et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999, 286(5448):2328-2331.
31. Dupont S., Dennefeld C., Krust A., Chambon P., Mark M. Expression of Sox9 in granulosa cells lacking the estrogen receptors, ERalpha and ERbeta. Dev Dyn 2003, 226(1):103-106.
32. Kanai Y., Koopman P. Structural and functional characterization of the mouse Sox9 promoter: implications for campomelic dysplasia. Hum Mol Genet 1999, 8(4):691-696.
33. Morais da Silva S., Hacker A., Harley V., Goodfellow P., Swain A., Lovell-Badge R. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 1996, 14(1):62-68.
34. Winuthayanon W., Hewitt S.C., Orvis G.D., Behringer R.R., Korach K.S. Uterine epithelial estrogen receptor alpha is dispensable for proliferation but essential for complete biological and biochemical responses. Proc Natl Acad Sci USA 2010, 107(45):19272-19277. [epub 27.10.10].
35. Bridges P.J., Koo Y., Kang D.-W., Hudgins-Spivey S., Lan Z.-J., Xu X., et al. Generation of Cyp17iCre transgenic mice and their application to conditionally delete estrogen receptor alpha (Esr1) from the ovary and testis. Genesis 2008, 46(9):499-505.
36. Matic M., Bryzgalova G., Gao H., Antonson P., Humire P., Omoto Y., et al. Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action. PLOS ONE 2013, 8(2):e57458. [epub 02.03.13].
37. Singh S.P., Wolfe A., Ng Y., DiVall S.A., Buggs C., Levine J.E., et al. Impaired estrogen feedback and infertility in female mice with pituitary-specific deletion of estrogen receptor alpha (ESR1). Biol Reprod 2009, 81(3):488-496. [epub 15.05.09].
38. Sanchez-Criado J.E., Trudgen K., Millan Y., Blanco A., Monterde J., Garrido-Gracia J.C., et al. Estrogen receptor (ESR) 2 partially offsets the absence of ESR1 in gonadotropes of pituitary-specific Esr1 knockout female mice. Reprod (Camb) 2012, 143(4):549-558. [epub 01.03.12].
39. Ribas V., Drew B.G., Le J.A., Soleymani T., Daraei P., Sitz D., et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA 2011, 108(39):16457-16462. [epub 09.09.11].
40. Jakacka M., Ito M., Martinson F., Ishikawa T., Lee E.J., Jameson J.L. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 2002, 16(10):2188-2201.
41. Ahlbory-Dieker D.L., Stride B.D., Leder G., Schkoldow J., Trolenberg S., Seidel H., et al. DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Molr Endocrinol 2009, 23(10):1544-1555. [epub 04.07.09].
42. Sinkevicius K.W., Burdette J.E., Woloszyn K., Hewitt S.C., Hamilton K., Sugg S.L., et al. An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology 2008, 149(6):2970-2979. [epub 15.03.08].
43. Billon-Gales A., Krust A., Fontaine C., Abot A., Flouriot G., Toutain C., et al. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci USA 2011, 108(32):13311-13316. [epub 27.07.11].
44. Billon-Gales A., Fontaine C., Filipe C., Douin-Echinard V., Fouque M.J., Flouriot G., et al. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci USA 2009, 106(6):2053-2058. [epub 04.02.09].
45. Arao Y., Hamilton K.J., Ray M.K., Scott G., Mishina Y., Korach K.S. Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators. Proc Natl Acad Sci USA 2011, 108(36):14986-14991. [epub 30.08.11].
46. Klotz D.M., Hewitt S.C., Ciana P., Raviscioni M., Lindzey J.K., Foley J., et al. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2002, 277(10):8531-8537.
47. Curtis S.W., Washburn T., Sewall C., DiAugustine R., Lindzey J., Couse J.F., et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 1996, 93(22):12626-12630.
48. Arao Y., Hamilton K.J., Goulding E.H., Janardhan K.S., Eddy E.M., Korach K.S. Transactivating function (AF) 2-mediated AF-1 activity of estrogen receptor alpha is crucial to maintain male reproductive tract function. Proc Natl Acad Sci USA 2012, 109(51):21140-21145. [epub 06.12.12].